Related Experiment Video
Updated: Jan 21, 2026

Whole Genome Sequencing of Candida glabrata for Detection of Markers of Antifungal Drug Resistance
Published on: December 28, 2017
Antifungal resistance in dermatophytes: Recent trends and therapeutic implications
Ananta Khurana1, Kabir Sardana1, Anuradha Chowdhary2
1Department of Dermatology, Postgraduate Institute of Medical Education and Research, Dr Ram Manohar Lohia Hospital, New Delhi 110001, India.
Abstract:
Dermatophytoses or tinea refers to superficial fungal infection of keratinized tissues. Although generally considered easy to treat, recalcitrant infections, presenting as extensive and difficult to treat tinea corporis and cruris, are on the rise in some parts of the world. The situation demands an understanding of the pharmacokinetic and pharmacodynamic properties of the available antifungals against dermatophytes and the possible contribution of drug resistance and other factors to the present scenario. In this review, we provide the readers a comprehensive account of the available literature on in-vitro and in-vivo resistance to clinically used antifungals among dermatophytes. We have also added, in brief, the relevant skin pharmacokinetics of important systemic drugs. The established and postulated mechanisms of drug resistance are discussed and aspects on lack of in vivo correlation of in vitro resistance are presented. Finally, the lacunae in our existing knowledge on the topic and the arenas for future research are highlighted.
Insights
Recalcitrant dermatophyte infections, or tinea, are increasing globally. This review examines antifungal drug resistance in dermatophytes and highlights knowledge gaps for future research.
Area of Science:
- Dermatology
- Mycology
- Pharmacology
Background:
- Dermatophytoses (tinea) are superficial fungal infections.
- Recalcitrant cases of tinea corporis and cruris are becoming more prevalent worldwide.
- Understanding antifungal resistance is crucial for effective treatment.
Purpose of the Study:
- To review in-vitro and in-vivo antifungal resistance in dermatophytes.
- To discuss pharmacokinetic properties of systemic antifungal drugs.
- To explore mechanisms of drug resistance and research gaps.
Main Methods:
- Comprehensive literature review of antifungal resistance in dermatophytes.
- Analysis of in-vitro and in-vivo studies.
- Inclusion of skin pharmacokinetics of systemic antifungals.
Main Results:
- Dermatophyte resistance to antifungals is a growing concern.
- Mechanisms of drug resistance are discussed.
- Discrepancies between in-vitro and in-vivo resistance data are presented.
Conclusions:
- Further research is needed to address antifungal resistance in dermatophytoses.
- Understanding drug resistance mechanisms and in-vivo correlations is essential.
- Future research should focus on improving treatment strategies for recalcitrant tinea.
Related Concept Videos
Current Trends in Nursing I
Current Trends in Nursing II
Issues And Trends In Healthcare Delivery System
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Trends in Lattice Energy: Ion Size and Charge
Resistivity
Resistance

